CTAC NV (CTAC.AS) Fundamental Analysis & Valuation

AMS:CTAC • NL0000345577

Current stock price

2.8 EUR
-0.1 (-3.45%)
Last:

This CTAC.AS fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

4

1. CTAC.AS Profitability Analysis

1.1 Basic Checks

  • CTAC had positive earnings in the past year.
  • In the past year CTAC had a positive cash flow from operations.
  • CTAC had positive earnings in each of the past 5 years.
  • CTAC had a positive operating cash flow in each of the past 5 years.
CTAC.AS Yearly Net Income VS EBIT VS OCF VS FCFCTAC.AS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5M 10M 15M

1.2 Ratios

  • Looking at the Return On Assets, with a value of 7.74%, CTAC belongs to the top of the industry, outperforming 80.56% of the companies in the same industry.
  • CTAC's Return On Equity of 16.41% is fine compared to the rest of the industry. CTAC outperforms 72.22% of its industry peers.
  • CTAC's Return On Invested Capital of 9.71% is fine compared to the rest of the industry. CTAC outperforms 61.11% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for CTAC is in line with the industry average of 10.82%.
Industry RankSector Rank
ROA 7.74%
ROE 16.41%
ROIC 9.71%
ROA(3y)3.98%
ROA(5y)4.84%
ROE(3y)8.98%
ROE(5y)11.99%
ROIC(3y)10.26%
ROIC(5y)11.02%
CTAC.AS Yearly ROA, ROE, ROICCTAC.AS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15

1.3 Margins

  • CTAC has a Profit Margin (2.86%) which is comparable to the rest of the industry.
  • In the last couple of years the Profit Margin of CTAC has declined.
  • With a Operating Margin value of 2.63%, CTAC is not doing good in the industry: 70.83% of the companies in the same industry are doing better.
  • In the last couple of years the Operating Margin of CTAC has declined.
  • Looking at the Gross Margin, with a value of 35.24%, CTAC is doing worse than 66.67% of the companies in the same industry.
  • CTAC's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 2.63%
PM (TTM) 2.86%
GM 35.24%
OM growth 3Y-12.38%
OM growth 5Y-6.66%
PM growth 3Y-10.68%
PM growth 5Y-3.79%
GM growth 3Y-5.01%
GM growth 5Y-4.72%
CTAC.AS Yearly Profit, Operating, Gross MarginsCTAC.AS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. CTAC.AS Health Analysis

2.1 Basic Checks

  • CTAC has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
  • The number of shares outstanding for CTAC remains at a similar level compared to 1 year ago.
  • CTAC has more shares outstanding than it did 5 years ago.
  • CTAC has a better debt/assets ratio than last year.
CTAC.AS Yearly Shares OutstandingCTAC.AS Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M
CTAC.AS Yearly Total Debt VS Total AssetsCTAC.AS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M

2.2 Solvency

  • CTAC has an Altman-Z score of 4.00. This indicates that CTAC is financially healthy and has little risk of bankruptcy at the moment.
  • CTAC has a Altman-Z score of 4.00. This is amongst the best in the industry. CTAC outperforms 84.72% of its industry peers.
  • CTAC has a Debt/Equity ratio of 0.16. This is a healthy value indicating a solid balance between debt and equity.
  • The Debt to Equity ratio of CTAC (0.16) is better than 73.61% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.16
Debt/FCF N/A
Altman-Z 4
ROIC/WACC1.51
WACC6.43%
CTAC.AS Yearly LT Debt VS Equity VS FCFCTAC.AS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10M 20M 30M

2.3 Liquidity

  • CTAC has a Current Ratio of 1.10. This is a normal value and indicates that CTAC is financially healthy and should not expect problems in meeting its short term obligations.
  • CTAC has a Current ratio of 1.10. This is in the lower half of the industry: CTAC underperforms 63.89% of its industry peers.
  • A Quick Ratio of 1.10 indicates that CTAC should not have too much problems paying its short term obligations.
  • CTAC has a Quick ratio (1.10) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 1.1
Quick Ratio 1.1
CTAC.AS Yearly Current Assets VS Current LiabilitesCTAC.AS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. CTAC.AS Growth Analysis

3.1 Past

  • The earnings per share for CTAC have decreased by -7.93% in the last year.
  • The Earnings Per Share has been growing slightly by 2.95% on average over the past years.
  • Looking at the last year, CTAC shows a small growth in Revenue. The Revenue has grown by 1.11% in the last year.
  • The Revenue has been growing slightly by 7.56% on average over the past years.
EPS 1Y (TTM)-7.93%
EPS 3Y-9.43%
EPS 5Y2.95%
EPS Q2Q%-18.74%
Revenue 1Y (TTM)1.11%
Revenue growth 3Y2.23%
Revenue growth 5Y7.56%
Sales Q2Q%0.78%

3.2 Future

  • The Earnings Per Share is expected to decrease by 0.00% on average over the next years.
  • CTAC is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 7.04% yearly.
EPS Next Y16.07%
EPS Next 2Y7.74%
EPS Next 3Y0%
EPS Next 5YN/A
Revenue Next Year4.33%
Revenue Next 2Y4.24%
Revenue Next 3Y2.31%
Revenue Next 5Y7.04%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
  • The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
CTAC.AS Yearly Revenue VS EstimatesCTAC.AS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 50M 100M 150M
CTAC.AS Yearly EPS VS EstimatesCTAC.AS Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2020 2021 2022 2023 2024 2025 2026 2027 2028 0.1 0.2 0.3

More info and screens

Find the best growth stocksShow best growing peers

6

4. CTAC.AS Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 11.20, the valuation of CTAC can be described as very reasonable.
  • 88.89% of the companies in the same industry are more expensive than CTAC, based on the Price/Earnings ratio.
  • CTAC's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 25.23.
  • With a Price/Forward Earnings ratio of 8.45, the valuation of CTAC can be described as very reasonable.
  • CTAC's Price/Forward Earnings ratio is rather cheap when compared to the industry. CTAC is cheaper than 80.56% of the companies in the same industry.
  • CTAC is valuated cheaply when we compare the Price/Forward Earnings ratio to 22.42, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 11.2
Fwd PE 8.45
CTAC.AS Price Earnings VS Forward Price EarningsCTAC.AS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • 87.50% of the companies in the same industry are more expensive than CTAC, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 4.16
CTAC.AS Per share dataCTAC.AS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8 10

4.3 Compensation for Growth

  • CTAC's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)0.7
PEG (5Y)3.8
EPS Next 2Y7.74%
EPS Next 3Y0%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

5

5. CTAC.AS Dividend Analysis

5.1 Amount

  • CTAC has a Yearly Dividend Yield of 3.79%.
  • Compared to an average industry Dividend Yield of 2.78, CTAC pays a bit more dividend than its industry peers.
  • CTAC's Dividend Yield is rather good when compared to the S&P500 average which is at 1.89.
Industry RankSector Rank
Dividend Yield 3.79%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years1
CTAC.AS Yearly Dividends per shareCTAC.AS Yearly Dividends per shareYearly Dividends per share 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.02 0.04 0.06 0.08 0.1

5.3 Sustainability

  • 28.82% of the earnings are spent on dividend by CTAC. This is a low number and sustainable payout ratio.
DP28.82%
EPS Next 2Y7.74%
EPS Next 3Y0%
CTAC.AS Yearly Income VS Free CF VS DividendCTAC.AS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5M 10M
CTAC.AS Dividend Payout.CTAC.AS Dividend Payout, showing the Payout Ratio.CTAC.AS Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

CTAC.AS Fundamentals: All Metrics, Ratios and Statistics

CTAC NV

AMS:CTAC (3/20/2026, 7:00:00 PM)

2.8

-0.1 (-3.45%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)N/A
Earnings (Next)N/A
Inst Owners5.23%
Inst Owner ChangeN/A
Ins Owners22.27%
Ins Owner ChangeN/A
Market Cap39.62M
Revenue(TTM)188.71M
Net Income(TTM)5.40M
Analysts80
Price Target2.87 (2.5%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.79%
Yearly Dividend0.11
Dividend Growth(5Y)N/A
DP28.82%
Div Incr Years0
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-3.44%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-22.62%
EPS NY rev (3m)-22.62%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-5.36%
Valuation
Industry RankSector Rank
PE 11.2
Fwd PE 8.45
P/S 0.21
P/FCF N/A
P/OCF 62.99
P/B 1.2
P/tB 5.55
EV/EBITDA 4.16
EPS(TTM)0.25
EY8.93%
EPS(NY)0.33
Fwd EY11.84%
FCF(TTM)-0.06
FCFYN/A
OCF(TTM)0.04
OCFY1.59%
SpS13.34
BVpS2.33
TBVpS0.5
PEG (NY)0.7
PEG (5Y)3.8
Graham Number3.62
Profitability
Industry RankSector Rank
ROA 7.74%
ROE 16.41%
ROCE 12.62%
ROIC 9.71%
ROICexc 11%
ROICexgc 42.74%
OM 2.63%
PM (TTM) 2.86%
GM 35.24%
FCFM N/A
ROA(3y)3.98%
ROA(5y)4.84%
ROE(3y)8.98%
ROE(5y)11.99%
ROIC(3y)10.26%
ROIC(5y)11.02%
ROICexc(3y)12.83%
ROICexc(5y)13.89%
ROICexgc(3y)121.73%
ROICexgc(5y)145.43%
ROCE(3y)13.49%
ROCE(5y)14.56%
ROICexgc growth 3Y-18.29%
ROICexgc growth 5Y-22.64%
ROICexc growth 3Y-9.77%
ROICexc growth 5Y-4.88%
OM growth 3Y-12.38%
OM growth 5Y-6.66%
PM growth 3Y-10.68%
PM growth 5Y-3.79%
GM growth 3Y-5.01%
GM growth 5Y-4.72%
F-Score6
Asset Turnover2.71
Health
Industry RankSector Rank
Debt/Equity 0.16
Debt/FCF N/A
Debt/EBITDA 0.52
Cap/Depr 28.44%
Cap/Sales 0.81%
Interest Coverage 13.63
Cash Conversion 6.08%
Profit Quality N/A
Current Ratio 1.1
Quick Ratio 1.1
Altman-Z 4
F-Score6
WACC6.43%
ROIC/WACC1.51
Cap/Depr(3y)42.32%
Cap/Depr(5y)33.13%
Cap/Sales(3y)1.77%
Cap/Sales(5y)1.43%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-7.93%
EPS 3Y-9.43%
EPS 5Y2.95%
EPS Q2Q%-18.74%
EPS Next Y16.07%
EPS Next 2Y7.74%
EPS Next 3Y0%
EPS Next 5YN/A
Revenue 1Y (TTM)1.11%
Revenue growth 3Y2.23%
Revenue growth 5Y7.56%
Sales Q2Q%0.78%
Revenue Next Year4.33%
Revenue Next 2Y4.24%
Revenue Next 3Y2.31%
Revenue Next 5Y7.04%
EBIT growth 1Y-10.74%
EBIT growth 3Y-10.42%
EBIT growth 5Y0.4%
EBIT Next Year118.18%
EBIT Next 3Y29.7%
EBIT Next 5YN/A
FCF growth 1Y-112.89%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-93.88%
OCF growth 3Y-52.08%
OCF growth 5Y-47.08%

CTAC NV / CTAC.AS Fundamental Analysis FAQ

What is the fundamental rating for CTAC stock?

ChartMill assigns a fundamental rating of 5 / 10 to CTAC.AS.


Can you provide the valuation status for CTAC NV?

ChartMill assigns a valuation rating of 6 / 10 to CTAC NV (CTAC.AS). This can be considered as Fairly Valued.


Can you provide the profitability details for CTAC NV?

CTAC NV (CTAC.AS) has a profitability rating of 5 / 10.


What is the financial health of CTAC NV (CTAC.AS) stock?

The financial health rating of CTAC NV (CTAC.AS) is 5 / 10.


Can you provide the dividend sustainability for CTAC stock?

The dividend rating of CTAC NV (CTAC.AS) is 6 / 10 and the dividend payout ratio is 28.82%.